Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03414658
Title The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ian E. Krop, MD, PhD

Her2-receptor positive breast cancer


Avelumab + Trastuzumab + Utomilumab + Vinorelbine

Avelumab + Trastuzumab + Vinorelbine

Avelumab + Trastuzumab + Utomilumab

Trastuzumab + Vinorelbine

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.